Giving ADMA Biologics A Well-Deserved Booyah - Seeking Alpha
ADMA Stock | USD 19.69 0.49 2.55% |
About 65% of all ADMA Biologics' investors are looking to take a long position. The analysis of the overall investor sentiment regarding ADMA Biologics suggests that some traders are interested. The current market sentiment, together with ADMA Biologics' historical and current headlines, can help investors time the market. In addition, many technical investors use ADMA Biologics stock news signals to limit their universe of possible portfolio assets.
Giving ADMA Biologics A Well-Deserved Booyah Seeking Alpha
Read at news.google.com
![]() |
ADMA Biologics Current Investor Sentiment
Comfort Level 65
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use ADMA Biologics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward ADMA Biologics.
News SentimentBullish | Hype SentimentBullish | Insider SentimentDisposing |
ADMA Biologics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards ADMA Biologics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
ADMA Biologics Historical Investor Sentiment
Investor biases related to ADMA Biologics' public news can be used to forecast risks associated with an investment in ADMA. The trend in average sentiment can be used to explain how an investor holding ADMA can time the market purely based on public headlines and social activities around ADMA Biologics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ADMA Biologics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ADMA Biologics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average ADMA Biologics news discussions. The higher the estimate score, the more favorable the investor's outlook on ADMA Biologics.
ADMA Biologics Fundamental Analysis
We analyze ADMA Biologics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ADMA Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ADMA Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
ADMA Biologics is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
ADMA Biologics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ADMA Biologics stock to make a market-neutral strategy. Peer analysis of ADMA Biologics could also be used in its relative valuation, which is a method of valuing ADMA Biologics by comparing valuation metrics with similar companies.
Peers
ADMA Biologics Related Equities
TNXP | Tonix Pharmaceuticals | 26.54 | ||||
CDTX | Cidara Therapeutics | 21.25 | ||||
VXRT | Vaxart | 20.26 | ||||
CRBU | Caribou Biosciences | 14.44 | ||||
FATE | Fate Therapeutics | 11.46 | ||||
MCRB | Seres Therapeutics | 10.49 | ||||
IBIO | IBio, Common | 9.52 | ||||
INMB | INmune Bio | 7.82 | ||||
AKBA | Akebia Ther | 6.53 | ||||
ANEB | Anebulo Pharmaceuticals | 4.08 | ||||
ETNB | 89bio | 1.83 | ||||
STOK | Stoke Therapeutics | 1.35 | ||||
PLX | Protalix Biotherapeutics | 0.60 | ||||
ACLX | Arcellx | 0.56 | ||||
BCRX | BioCryst Pharmaceuticals | 0.29 | ||||
SANA | Sana Biotechnology | 0.00 | ||||
PLRX | Pliant Therapeutics | 0.00 | ||||
RCUS | Arcus Biosciences | 0.12 | ||||
MDGL | Madrigal Pharmaceuticals | 0.29 | ||||
ANTX | AN2 Therapeutics | 2.44 | ||||
XFOR | X4 Pharmaceuticals | 3.31 | ||||
ATRA | Atara Biotherapeutics | 10.12 |
Complementary Tools for ADMA Stock analysis
When running ADMA Biologics' price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |